Stocks
Regencell Bioscience Holdings LimitedRGC
NASDAQHealthcareBiotechnology$23.23-3.21%
Specializing in traditional Chinese medicine, this biopharmaceutical company develops treatments for neurocognitive disorders and ADHD. Its $11.5B valuation reflects investor interest in alternative therapies with large addressable markets.
Market Cap: $11.5B52W Range: $0.33 – $83.60
Congressional Interest in Regencell Bioscience Holdings Limited (RGC)
7 members of Congress have disclosed 19 trades in Regencell Bioscience Holdings Limited (RGC), a Healthcare company. The buy/sell breakdown shows 5 purchases versus 14 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
19
Unique Politicians
7
Buys
5
Sells
14
Who in Congress Is Trading RGC?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2018-01-09 | Lois Frankel | sell | $1K – $15K |
| 2018-01-08 | Lois Frankel | sell | $1K – $15K |